References
- The principle investigators of the MONICA Project. WHO MONICA Project. Geographic Variation in mortality from cardiovascular diseases. Wld. hlth. statist, quart. 1987; 40: 171–184
- Leparski E, Nüssel E. CINDI. Countrywide inte-grated non-communicable diseases intervention programme. Protocol and guidelines for monitoring and evaluation procedures. Springer-Verlag, Berlin Heidelberg New York London Paris Tokyo 1987
- ERICA Research Group. The CHD risk-map of Europe. The 1 st report of the WHO-ERIC A project. European Heart Journal 1988, Suppl. I
- Report from the committee of principal investigators. A cooperative trial in the primary prevention of ischaemic heart disease using Clofibrate. Brit. Heart J. 1978; 40: 1069
- Grafnetter D. World Health Organization (WHO) coordinated quality control in the lipid laboratory, iorn. Arterioscl. 1977; 2: 113–128
- Grafnetter D, Valek J. Choice and standardization of lipid methods in cooperative population studies. Proceedings of the “2nd Dresdner Lipidsymposium” Dresden. May, 1976, 49–57
- Grafnetter D. External quality control carried out by the WHO European Reference Center in Prague. International Conference on Atherosclerosis, L Carlson, et al. Raven Press, New York 1978; 379–386
- Grafnetter D. WHO lipid reference programme. A quality control substudy in socialist countries withuse of Precilip E. L. samples. Prague. Proceedings of the symposium “Lipid methods and their quality control”. 1980, Editor:Boehringer Mannheim GmbH.
- Grafnetter D. Problems of standardization of different lipid methods in international studies. Przeklad lekarski 1985; 42: 607–613
- Grafnetter D. Erfahrungen und Tendenzen bei der internationalen Standardisierung lipidanalytischen Verfahren. Dresden. Proceedings of the “3rd Dresdner Lipidsymposium”. 1979
- MONICA Manual. WHO publication WHO/MNC/Rev. 2. Section 6: Standardization of lipid measurements. Section 7: Standardization of Thiocyanate measurements
- Lipid standardization programme of the Centers for Disease Control. January, 1983, Internal publication of the Centers for Disease Control Atlanta Ga. USA
- The Centers for Disease Control-National Heart Lungand Blood Institute High Density Lipoprotein Cholesterol Standardization Program. October, 1980, Internal publication of the Centers for Disease Control Atlanta Ga. USA
- The Lipid Research Clinics. Coronary primary prevention trial results. I. Reduction in incidence of coronary heart disease. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984; 251: 351
- Duncan I W, Mather A, Cooper G R. The procedure for the proposed cholesterol Reference Method. Centers for Disease control, Atlanta Ga 1982
- Abell L L, Levy B B, Brodie B B, Kendall F E. Simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J. Biol. Chem. 1952; 195: 357–366
- Grafnetter D. On the role of the CHOD-PAP “High-performance” cholesterol method in quality assurance work. Biochem. clin. bohemoslov. 1986; 15: 209–217
- Naito H K. Problems asociated with lipid and lipoprotein analyses. Detection and treatment of lipid and lipoprotein disorders of childhood. Alan R. Liss Inc. 1985; 19–60
- Grafnetter D. Problems of standardization of different lipid methods in international studies. Przeklad lekarski 1985; 42: 607–613
- Grafnetter D. WHO lipid reference programme. Attempt to standardize dry chemistry cholesterol method. Intemational symposium on cholesterol control and cardiovascular diseases:prevention and therapy. Milan. 1987
- Grafnetter D, Teminova J, Weyher I, Nüssel E. Experiences with the Reflotron-Cholesterol-Method. Ärztl. Lab. 1989; 35: 80–88
- Bacchus R A, Bullock D G, Noy G A, Whitehead T P. The Middle East external quality assessment scheme for clinical chemistry. Ann Clin Biochem 1988; 25: 560–568
- The Australian Lipid Standardization Programme. Internal publication of the Australian Lipid Chemistry Working Party. 1989